Strategic guidance from
proven professionals

David Y. Mitchell, Ph.D.

Chief Scientific Officer

Dr. Mitchell has more than 28 years of progressive leadership experience in clinical pharmacology and pharmacokinetics (PK). Dr. Mitchell has extensive expertise in all phases of development. His focus is on protocol design and planning, clinical and nonclinical PK data analysis/simulation, pharmacodynamic data analysis/interpretation, and representation at regulatory meetings. Dr. Mitchell’s therapeutic area experience includes oncology, immunology, rheumatology, and rare diseases. Dr. Mitchell has worked on 10 NDAs, 2 ANDAs, 2 BLAs, 20+ INDs, 100+ PK and population PK analyses.


  • Post-doctoral Fellowship, Department of Pharmacology, Toxicology, & Therapeutics
    • University of Kansas School of Medicine, Kansas City, KS
  • Doctor of Philosophy, Pharmaceutical
    • University of Colorado, Boulder, CO
  • Bachelor of Science, Biological Sciences
    • University of Northern Colorado, Greeley, CO